articleTop 1% cited
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis
Journal of Neurology · 2012 · Vol. 260(4) · pp. 984–997
Richard Langford✉(St Bartholomew's Hospital)Jan Mareš(University Hospital Olomouc)Alena Novotná(Nemocnice Pardubického Kraje)Marta Vachová(Regional Museum in Teplice)Iveta NovákováWilliam Notcutt(James Paget University Hospital)S. Ratcliffe
Cannabis and Cannabinoid ResearchPoisoning and overdose treatmentsToxin Mechanisms and ImmunotoxinsMedicinePlaceboRandomized controlled trialCannabidiolAnesthesiaClinical endpointInterim analysisNeuropathic painInternal medicineCannabis
MeSH terms
Administration, OralAdultAnalysis of VarianceCannabidiolDouble-Blind MethodDrug Therapy, CombinationFemaleFollow-Up StudiesHumansMaleMiddle AgedMultiple SclerosisNeuralgiaPain MeasurementDronabinol
Funding
- GW Pharmaceuticals
Citations
292
FWCI
12.18
field-weighted impact
References
29
Percentile
99%
vs. same field & year
Citations per year
References
The orphan receptor GPR55 is a novel cannabinoid receptor
British Journal of Pharmacology · 2007 · 1,550 citations
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Pain · 2007 · 2,109 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.